Debby Ngo

2-Aminoadipic acid is a biomarker for diabetes risk

Thomas J. Wang, Debby Ngo, Nikolaos Psychogios et al. · Journal of Clinical Investigation · 2013 · 468 citations · Full text

Life Sciences, Biochemistry, Metabolic Regulation +13

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Michael R. Filbin, Arnav Mehta, Alexis M. Schneider et al. · Cell Reports Medicine · 2021 · 309 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease

Debby Ngo, Sumita Sinha, Dongxiao Shen et al. · Circulation · 2016 · 217 citations · Full text

Medicine, Cardiology, Molecular Medicine +17

Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Daniel H. Katz, Jeremy Robbins, Shuliang Deng et al. · Science Advances · 2022 · 207 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Comparison of Proteomic Assessment Methods in Multiple Cohort Studies

Laura M. Raffield, Hong Dang, Katherine Pratte et al. · PROTEOMICS · 2020 · 185 citations · Full text

Life Sciences, Biochemistry, Clinical Biochemistry +16